IBDEI1FN ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,748,0)
 ;;=CANCER & HEMATOLOGIC CONDITIONS^2^76
 ;;^UTILITY(U,$J,358.4,749,0)
 ;;=PALLIATIVE/HOSPICE ENCOUNTER^1^76
 ;;^UTILITY(U,$J,358.4,750,0)
 ;;=CNS CONDITIONS OTHER THAN CANCER^3^76
 ;;^UTILITY(U,$J,358.4,751,0)
 ;;=CARDIOPULMONARY COND OTHER THAN CANCER^4^76
 ;;^UTILITY(U,$J,358.4,752,0)
 ;;=GASTROINTESTINAL COND OTHER THAN CANCER^5^76
 ;;^UTILITY(U,$J,358.4,753,0)
 ;;=RENAL COND OTHER THAN CANCER^6^76
 ;;^UTILITY(U,$J,358.4,754,0)
 ;;=DERMATOLOGIC CONDITIONS^7^76
 ;;^UTILITY(U,$J,358.4,755,0)
 ;;=RHEUMATOLOGIC/VASCULITIC/THROMBOEMBOLIC^8^76
 ;;^UTILITY(U,$J,358.4,756,0)
 ;;=INFECTIOUS CONDITIONS & SIRS^9^76
 ;;^UTILITY(U,$J,358.4,757,0)
 ;;=HOSPICE CARE SUPERVISION^1^77
 ;;^UTILITY(U,$J,358.4,758,0)
 ;;=NEW PATIENT ^2^78
 ;;^UTILITY(U,$J,358.4,759,0)
 ;;=ESTABLISHED PATIENT ^1^78
 ;;^UTILITY(U,$J,358.4,760,0)
 ;;=CONSULTATIONS ^3^78
 ;;^UTILITY(U,$J,358.4,761,0)
 ;;=CANCER & HEMATOLOGIC CONDITIONS^2^79
 ;;^UTILITY(U,$J,358.4,762,0)
 ;;=PALLIATIVE/HOSPICE ENCOUNTER^1^79
 ;;^UTILITY(U,$J,358.4,763,0)
 ;;=CNS CONDITIONS OTHER THAN CANCER^4^79
 ;;^UTILITY(U,$J,358.4,764,0)
 ;;=CARDIOPULMONARY COND OTHER THAN CANCER^3^79
 ;;^UTILITY(U,$J,358.4,765,0)
 ;;=GASTROINTESTINAL COND OTHER THAN CANCER^6^79
 ;;^UTILITY(U,$J,358.4,766,0)
 ;;=RENAL COND OTHER THAN CANCER^8^79
 ;;^UTILITY(U,$J,358.4,767,0)
 ;;=DERMATOLOGIC CONDITIONS^5^79
 ;;^UTILITY(U,$J,358.4,768,0)
 ;;=RHEUMATOLOGIC/VASCULITIC/THROMBOEMBOLIC^9^79
 ;;^UTILITY(U,$J,358.4,769,0)
 ;;=INFECTIOUS CONDITIONS & SIRS^7^79
 ;;^UTILITY(U,$J,358.4,770,0)
 ;;=NEW PATIENT^2^80
 ;;^UTILITY(U,$J,358.4,771,0)
 ;;=ESTABLISHED PATIENT^1^80
 ;;^UTILITY(U,$J,358.4,772,0)
 ;;=CONSULTATIONS^3^80
 ;;^UTILITY(U,$J,358.4,773,0)
 ;;=PROCEDURES^1^81
 ;;^UTILITY(U,$J,358.4,774,0)
 ;;=CARDIOVASCULAR^2^82
 ;;^UTILITY(U,$J,358.4,775,0)
 ;;=DERMATOLOGY^3^82
 ;;^UTILITY(U,$J,358.4,776,0)
 ;;=GENERAL^1^82
 ;;^UTILITY(U,$J,358.4,777,0)
 ;;=EENT^4^82
 ;;^UTILITY(U,$J,358.4,778,0)
 ;;=ENDOCRINOLOGY^5^82
 ;;^UTILITY(U,$J,358.4,779,0)
 ;;=GI^6^82
 ;;^UTILITY(U,$J,358.4,780,0)
 ;;=HEMATOLOGY^7^82
 ;;^UTILITY(U,$J,358.4,781,0)
 ;;=HIV STATUS & RELATED DX^8^82
 ;;^UTILITY(U,$J,358.4,782,0)
 ;;=NEPHRO/GU^9^82
 ;;^UTILITY(U,$J,358.4,783,0)
 ;;=NEUROLOGY^10^82
 ;;^UTILITY(U,$J,358.4,784,0)
 ;;=PAIN^11^82
 ;;^UTILITY(U,$J,358.4,785,0)
 ;;=PSYCHIATRY/SUBSTANCE ABUSE^12^82
 ;;^UTILITY(U,$J,358.4,786,0)
 ;;=RHEUMATOLOGY^13^82
 ;;^UTILITY(U,$J,358.4,787,0)
 ;;=RESPIRATORY^14^82
 ;;^UTILITY(U,$J,358.4,788,0)
 ;;=CONTACT W/ HAZARDOUS SUBSTANCE^.5^82
 ;;^UTILITY(U,$J,358.4,789,0)
 ;;=INITIAL OBSERVATION^1^83
 ;;^UTILITY(U,$J,358.4,790,0)
 ;;=INPT BEDSIDE VISIT-INITIAL CARE^4^83
 ;;^UTILITY(U,$J,358.4,791,0)
 ;;=INPT-CONSULTATIONS^6^83
 ;;^UTILITY(U,$J,358.4,792,0)
 ;;=OBSERVATION DISCHARGE^3^83
 ;;^UTILITY(U,$J,358.4,793,0)
 ;;=INPT BEDSIDE VISITS-DAILY VISITS^5^83
 ;;^UTILITY(U,$J,358.4,794,0)
 ;;=ADMIT & DISCHARGE SAME DAY^7^83
 ;;^UTILITY(U,$J,358.4,795,0)
 ;;=DISCHARGE DAY CODES^8^83
 ;;^UTILITY(U,$J,358.4,796,0)
 ;;=OBSERVATION SUBSEQUENT VISIT^2^83
 ;;^UTILITY(U,$J,358.4,797,0)
 ;;=CARDIOVASCULAR^3^84
 ;;^UTILITY(U,$J,358.4,798,0)
 ;;=RESPIRATORY^13^84
 ;;^UTILITY(U,$J,358.4,799,0)
 ;;=MUSCULOSKELETAL^10^84
 ;;^UTILITY(U,$J,358.4,800,0)
 ;;=NEUROLOGIC^11^84
 ;;^UTILITY(U,$J,358.4,801,0)
 ;;=GASTROENTEROLOGY^5^84
 ;;^UTILITY(U,$J,358.4,802,0)
 ;;=GENITOURINARY^6^84
 ;;^UTILITY(U,$J,358.4,803,0)
 ;;=HEMATOLOGY/ONCOLOGY^7^84
 ;;^UTILITY(U,$J,358.4,804,0)
 ;;=INJURY/TRAUMA^8^84
 ;;^UTILITY(U,$J,358.4,805,0)
 ;;=SIGNS/SYMPTOMS^2^84
 ;;^UTILITY(U,$J,358.4,806,0)
 ;;=PAIN^12^84
